We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Top Buys

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$55.3M
2
AAPL icon
Apple
AAPL
+$33.2M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
MSFT icon
Microsoft
MSFT
+$26.4M
5
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$22.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$93.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$86M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$51.5M
5
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EIDX
2651
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$80K ﹤0.01%
+1,670
New +$77.7K
BX icon
2652
Blackstone
BX
$112B
$79K ﹤0.01%
1,393
-1,946
-58% -$102K
CPB icon
2653
Campbell Soup
CPB
$6.94B
$79K ﹤0.01%
1,590
-7,091
-82% -$352K
CSTL icon
2654
Castle Biosciences
CSTL
$933M
$79K ﹤0.01%
+2,108
New +$72K
EEM icon
2655
iShares MSCI Emerging Markets ETF
EEM
$30.5B
$79K ﹤0.01%
1,968
-2,296,391
-100% -$86M
FFWM
2656
DELISTED
First Foundation Inc
FFWM
$79K ﹤0.01%
4,847
+3,096
+177% +$41.6K
HIBL icon
2657
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$94M
$79K ﹤0.01%
+5,894
New +$69.4K
LBRDA icon
2658
Liberty Broadband Class A
LBRDA
$5.29B
$79K ﹤0.01%
646
+487
+306% +$59.9K
MTDR icon
2659
Matador Resources
MTDR
$6.39B
$79K ﹤0.01%
9,310
+7,132
+327% +$49.8K
MUFG icon
2660
Mitsubishi UFJ Financial
MUFG
$260B
$79K ﹤0.01%
20,110
+17,334
+624% +$68.6K
SIGA icon
2661
SIGA Technologies
SIGA
$207M
$79K ﹤0.01%
+13,358
New +$76.3K
TXG icon
2662
10x Genomics
TXG
$7.58B
$79K ﹤0.01%
+883
New +$68.8K
WASH icon
2663
Washington Trust Bancorp
WASH
$767M
$79K ﹤0.01%
2,405
+1,633
+212% +$53.4K
CDMO
2664
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$79K ﹤0.01%
+12,094
New +$67.5K
SCPL
2665
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$79K ﹤0.01%
+5,335
New +$65.5K
ATCX
2666
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$79K ﹤0.01%
+12,000
New +$109K
EMWP
2667
DELISTED
Eros Media World PLC
EMWP
$79K ﹤0.01%
+1,254
New +$70.7K
ODT
2668
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$79K ﹤0.01%
1,858
+438
+31% +$14.2K
MNK
2669
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$79K ﹤0.01%
+29,337
New +$88K
ACMR icon
2670
ACM Research
ACMR
$5.65B
$78K ﹤0.01%
3,768
+3,468
+1,156% +$56.9K
ADPT icon
2671
Adaptive Biotechnologies
ADPT
$3.89B
$78K ﹤0.01%
+1,606
New +$58.6K
BBT
2672
Beacon Financial Corp
BBT
$2.71B
$78K ﹤0.01%
7,036
+4,675
+198% +$60.1K
CACC icon
2673
Credit Acceptance
CACC
$6.05B
$78K ﹤0.01%
187
-1,281
-87% -$446K
FNV icon
2674
Franco-Nevada
FNV
$44.7B
$78K ﹤0.01%
556
+449
+420% +$59.7K
LMAT icon
2675
LeMaitre Vascular
LMAT
$1.87B
$78K ﹤0.01%
+2,937
New +$76.8K
105 106
107
108 109

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.